• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活诱导的基因组结构调查揭示了 Myc 的一个新增强子。

Survey of activation-induced genome architecture reveals a novel enhancer of Myc.

机构信息

The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.

Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.

出版信息

Immunol Cell Biol. 2023 Apr;101(4):345-357. doi: 10.1111/imcb.12626. Epub 2023 Feb 14.

DOI:10.1111/imcb.12626
PMID:36710659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10952581/
Abstract

The transcription factor Myc is critically important in driving cell proliferation, a function that is frequently dysregulated in cancer. To avoid this dysregulation Myc is tightly controlled by numerous layers of regulation. One such layer is the use of distal regulatory enhancers to drive Myc expression. Here, using chromosome conformation capture to examine B cells of the immune system in the first hours after their activation, we reveal a previously unidentified enhancer of Myc. The interactivity of this enhancer coincides with a dramatic, but discrete, spike in Myc expression 3 h post-activation. However, genetic deletion of this region, has little impact on Myc expression, Myc protein level or in vitro and in vivo cell proliferation. Examination of the enhancer deleted regulatory landscape suggests that enhancer redundancy likely sustains Myc expression. This work highlights not only the importance of temporally examining enhancers, but also the complexity and dynamics of the regulation of critical genes such as Myc.

摘要

转录因子 Myc 对驱动细胞增殖至关重要,而这一功能在癌症中经常失调。为了避免这种失调,Myc 受到多层次调控的严格控制。其中一个层次是利用远端调控增强子来驱动 Myc 的表达。在这里,我们使用染色体构象捕获技术,在免疫系统 B 细胞激活后的头几个小时内对其进行研究,揭示了 Myc 的一个以前未被识别的增强子。该增强子的相互作用与激活后 3 小时 Myc 表达的显著但离散的尖峰相吻合。然而,该区域的基因缺失对 Myc 的表达、Myc 蛋白水平或体外和体内细胞增殖几乎没有影响。对缺失增强子的调控景观的研究表明,增强子冗余可能维持了 Myc 的表达。这项工作不仅强调了对增强子进行时间上研究的重要性,还强调了像 Myc 这样的关键基因的调控的复杂性和动态性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/3b74c6cee819/IMCB-101-345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/27c604e1ca0d/IMCB-101-345-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/bfef6b8477dc/IMCB-101-345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/6b8c3d6370a6/IMCB-101-345-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/b141a4740807/IMCB-101-345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/3b74c6cee819/IMCB-101-345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/27c604e1ca0d/IMCB-101-345-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/bfef6b8477dc/IMCB-101-345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/6b8c3d6370a6/IMCB-101-345-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/b141a4740807/IMCB-101-345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ad/10952581/3b74c6cee819/IMCB-101-345-g002.jpg

相似文献

1
Survey of activation-induced genome architecture reveals a novel enhancer of Myc.激活诱导的基因组结构调查揭示了 Myc 的一个新增强子。
Immunol Cell Biol. 2023 Apr;101(4):345-357. doi: 10.1111/imcb.12626. Epub 2023 Feb 14.
2
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.一个 Myc 增强子簇调节正常和白血病造血干细胞层级。
Nature. 2018 Jan 25;553(7689):515-520. doi: 10.1038/nature25193. Epub 2018 Jan 17.
3
NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.免疫球蛋白重链增强子对c-myc表达的失调需要NF-κB活性。
J Biol Chem. 2000 Oct 13;275(41):32338-46. doi: 10.1074/jbc.M004148200.
4
Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.远距离增强子活性决定了T细胞白血病中Myc对Notch抑制剂的敏感性。
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E4946-53. doi: 10.1073/pnas.1407079111. Epub 2014 Nov 4.
5
Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.增强子相关重排的检测揭示了B细胞淋巴瘤中癌基因失调的机制。
Cancer Discov. 2015 Oct;5(10):1058-71. doi: 10.1158/2159-8290.CD-15-0370. Epub 2015 Jul 30.
6
Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.在浆细胞瘤×成纤维细胞环境中IgH 3'增强子活性和c-myc表达的协同下调:对易位c-myc失调的影响
Mol Immunol. 1997 Feb;34(2):97-107. doi: 10.1016/s0161-5890(97)00017-5.
7
Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.伯基特淋巴瘤中可变免疫球蛋白重链增强子活性提示c-myc失调的另一种直接机制。
J Immunol. 1993 Jun 15;150(12):5418-28.
8
Identification of two enhancer elements downstream of the human c-myc gene.人类c-myc基因下游两个增强子元件的鉴定。
Nucleic Acids Res. 1995 Jan 11;23(1):72-80. doi: 10.1093/nar/23.1.72.
9
Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.在c-myc的内源性靶基因处对不同E盒结合蛋白的区分。
Genes Dev. 1996 Feb 15;10(4):447-60. doi: 10.1101/gad.10.4.447.
10
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.富含H3K27Ac的增强子区域的BRD4破坏与默克尔细胞癌中c-Myc表达降低相关。
Epigenetics. 2015;10(6):460-6. doi: 10.1080/15592294.2015.1034416. Epub 2015 May 5.

本文引用的文献

1
Shedding Structured Light on Molecular Immunity: The Past, Present and Future of Immune Cell Super Resolution Microscopy.解析分子免疫的结构之光:免疫细胞超高分辨率显微镜的过去、现在和未来。
Front Immunol. 2021 Dec 15;12:754200. doi: 10.3389/fimmu.2021.754200. eCollection 2021.
2
B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers.B1a 和 B2 细胞的特征是在 DNMT3A 维持的增强子处具有不同的 CpG 修饰状态。
Nat Commun. 2021 Apr 13;12(1):2208. doi: 10.1038/s41467-021-22458-9.
3
Pre-mitotic genome re-organisation bookends the B cell differentiation process.
有丝分裂前基因组重组为 B 细胞分化过程画上了句号。
Nat Commun. 2021 Feb 26;12(1):1344. doi: 10.1038/s41467-021-21536-2.
4
Enhancer redundancy in development and disease.增强子冗余在发育和疾病中的作用。
Nat Rev Genet. 2021 May;22(5):324-336. doi: 10.1038/s41576-020-00311-x. Epub 2021 Jan 12.
5
Identification and characterization of the long noncoding RNA Dreg1 as a novel regulator of Gata3.鉴定和描述长非编码 RNA Dreg1 作为 Gata3 的新型调控因子。
Immunol Cell Biol. 2021 Mar;99(3):323-332. doi: 10.1111/imcb.12408. Epub 2020 Oct 17.
6
Enhancer Domains Predict Gene Pathogenicity and Inform Gene Discovery in Complex Disease.增强子域预测复杂疾病中的基因致病性并为基因发现提供信息。
Am J Hum Genet. 2020 Feb 6;106(2):215-233. doi: 10.1016/j.ajhg.2020.01.012.
7
Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation.定量分析 Myc 在 T 细胞激活过程中如何控制 T 细胞蛋白质组和代谢途径。
Elife. 2020 Feb 5;9:e53725. doi: 10.7554/eLife.53725.
8
Polycomb repressive complex 2 is a critical mediator of allergic inflammation.多梳抑制复合物 2 是过敏炎症的关键介质。
JCI Insight. 2019 May 16;4(10). doi: 10.1172/jci.insight.127745.
9
The cis-Regulatory Atlas of the Mouse Immune System.小鼠免疫系统的顺式调控图谱。
Cell. 2019 Feb 7;176(4):897-912.e20. doi: 10.1016/j.cell.2018.12.036. Epub 2019 Jan 24.
10
The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.MYC增强子组:癌症中MYC的远程转录调控
Trends Cancer. 2018 Dec;4(12):810-822. doi: 10.1016/j.trecan.2018.10.003. Epub 2018 Nov 2.